Rafael Arroyo-Montañés

Mr. Rafael Arroyo-Montañés

Hospital Universitario Doctor Peset, Valencia, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
AAAnxo Rio-Vilariño Delia Acevedo-León
Anxo Rio-Vilariño Delia Acevedo-León
SGSegundo Ángel Gómez-Abril
Segundo Ángel Gómez-Abril
LMLidia Monzó-Beltrán
Lidia Monzó-Beltrán
NENuria Estañ-Capell
Nuria Estañ-Capell
RARafael Arroyo-Montañés
Rafael Arroyo-Montañés
Guillermo T SáezGuillermo T Sáez
Guillermo T Sáez
Oxidative stress (OS) and inflammation have been related to colorectal cancer (CRC), but the influence of the Mediterranean diet (MD) on these parameters is unknown. Therefore, the aim of this study was to determine the association between adherence to the MD and markers of OS and DNA damage in CRC patients and to study the influence of adherence to the MD on metabolic and tumor-related factors. This prospective observational study included a total of 80 patients diagnosed with CRC. Adherence to the MD was estimated by the 14-item Mediterranean Diet Adherence Screener (MEDAS) questionnaire. The levels of OS markers (catalase, glutathione peroxidase, and glutathione system in serum; 8-oxo-7′8-dihydro-2′-deoxyguanosine and F2-isoprotanes in urine) and tumor and metabolic factors were determined. A total of 51.2% of our CRC patients showed a high adherence to the MD. These patients presented decreased levels of 8-oxodG, increased GPX and HDL–cholesterol levels, and a downward trend in the GSSG/GSH ratio with respect to patients with low adherence to the MD. In addition, a high adherence to the MD was associated with a lower histological grade of the tumor and a lower presence of synchronous adenomas. We conclude that a high adherence to the MD has a protective role against metabolic and oxidative DNA damage and improves antioxidant systems in CRC patients.